"We Envision Growth Strategies Most Suited
to Your Business"

Cannabis Market to Grow to Reach USD 197.74 Billion by 2028; Rising Awareness Regarding the Products Medicinal and Therapeutic Benefits to Foster Market Development

November 09, 2021 | Food & Beverages

The global cannabis market size is anticipated to grow significantly by reaching USD 197.74 billion by 2028. Fortune Business Insights™ in its report titled “Cannabis/Marijuana Market Size, Share and COVID-19 Impact Analysis, By Type (Flowers/Buds and Concentrates), By Application (Medical, Recreational (Edibles and Topicals), and Industrial Hemp), and Regional Forecast, 2021 – 2028” observes that the market size stood at USD 20.47 billion in 2020 and is projected to exhibit a CAGR of 32.04% during 2021 and 2028. Rising awareness regarding the product’s therapeutic and medicinal benefits, enabling policies, and relaxation regulations are likely to foster the growth of the market.


Tokyo Smoke Opens Planned 9 Brick-and mortar Retail Franchised Cannabis Across Ontario for Market Expansion


Tokyo smoke, a Canopy Growth Corporation’s retail brand, announced its opening of 9 brick-and-mortar retail franchise cannabis locations across Ontario in January 2021. The opening of new stores shall help increase consumer demand and offer convenient and safe access to high-quality and legal marijuana. It will offer the local communities safe and high-quality products. The store adheres to COVID-19 safety measures and offers consumers the convenience of getting high-quality marijuana products. This strategy may help the company to expand its market and boost its consumer base.


To get a detailed report summary and research scope of this market, click here:


https://www.fortunebusinessinsights.com/industry-reports/cannabis-marijuana-market-100219


Rising Adoption from Medical Sectors and Availability of Marijuana Incorporated Edibles to Boost Market Growth


It is used extensively in the medical sector to manufacture anti-depressant drugs, cancer medicines, and other medicines. The rising awareness regarding its benefits is expected to boost its sales. The availability of a wide variety of flavors and edibles is expected to boost the product’s adoption. The product's availability in candies, chocolates, and beverages is expected to boost its popularity and enable users to enjoy the substance for an hour or two. Furthermore, marijuana’s demand is increasing rapidly from the medical sector because of relaxation policies. Several countries have placed favorable policies legalizing marijuana’s adoption in medicines. It is used to treat AIDS, cancer, and other disorders, which, in turn, is expected to boost its demand. In addition, its adoption by mainstream medical professionals is increasing because of its ability to treat arthritis, anorexia, and other disorders. These factors are likely to drive the cannabis market growth.


Companies Acquire Crucial Players to Expand their Product Portfolio


The prominent companies operating in the market devise acquisition strategies to expand their product portfolio. For example, Supreme Cannabis Company, Inc. and the Canopy Growth Corporation entered an agreement to acquire Supreme Cannabis by Canopy Company, Inc. in April 2021. This acquisition shall help Canopy Growth Corporation expand its product portfolio, attract consumers, and improve its brand position globally. Further, the launch of innovative products may enable manufacturers to satisfy consumer demand and enhance their brand image.


Industry Development



  • December 2020: A leading company named Aphria Inc. and Tilray, Inc reached an agreement to combine their business and transform into the world’s biggest marijuana manufacturer. The company shall be backed by state-of-the-art manufacturing, processing, and affordable costs to offer a portfolio of such products in Canada.


LIST OF KEY COMPANIES PROFILED:



  • Aurora Cannabis Inc. (Edmonton, Canada)

  • Tilary, Inc. (Nanaimo, Canada)

  • Canopy Growth Corporation (Ontario, Canada)

  • CannTrust Holdings Inc. (Vaughan, Canada)

  • VIVO Cannabis Inc. (Greater Napanee, Canada)

  • Cronos Group Inc. (Toronto, Canada)

  • Jazz Pharmaceuticals (Dublin, Ireland)

  • OrganiGram Holdings (Moncton, Canada)

  • Lexaria Corp. (Kelowna, Canada)

  • ABcann Medicinals, Inc. (Ontario Canada)


Further Report Findings



  • The market in North America stood at USD 19.78 billion in 2020 and is expected to gain the largest portion of the global market share. Marijuana’s legalization in the U.S. is expected to boost its demand.

  • The District of Columbia and Eleven states legalized the adoption of the product in 2019. The state medical cannabis law in the U.S. recognized the product as a medical drug to cure post-traumatic stress disorder, epilepsy, chronic pain, arthritis, and Alzheimer’s disease. In addition, the emergence of several marijuana growers is expected to boost the market growth.



  • According to type, the cannabis flower/bud segment is expected to hold the largest market share. The rapid popularity of marijuana leads to its adoption in vaporizers, which, in turn, may boost industry growth.


Table of Segmentation









































  ATTRIBUTE



  DETAILS



Study Period



2017-2028



Base Year



2020



Forecast Period



2021-2028



Historical Period



2017-2019



Unit



Value (USD Billion)



Segmentation



By Type



  • Flowers/Buds

  • Concentrates



By Application



  • Medical

  • Recreational

    • Edibles

    • Topicals



  • Industrial Hemp



 



By Region



  • North America (By Type, Application, and By Country)

    • U.S. (by Type)

    • Canada (by Type)

    • Mexico (by Type)



  • Europe (By Type, Application, and By Country)

    • Italy (by Type)

    • France (by Type)

    • Germany (by Type)

    • Belgium (by Type)

    • Czech Republic (by Type)

    • Rest of Europe (by Type)



  • Asia Pacific (By Type, Application, and By Country)

    • Australia (by Type)

    • Rest of Asia Pacific (by Type)



  • Rest of the World (By Type, Application, and By Country)

    • Brazil (by Type)

    • Zimbabwe (by Type)

    • Others in the Rest of the World (by Type)  




Cannabis Market
  • PDF
  • 2020
  • 2017-2019
  • 138

    CHOOSE LICENSE TYPE

  • 4850
    5850
    7850

Our Clients

UBS
Saint Gobain
Health Canada
Samsung
GM
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X